- Home
- LEE vs PLX Comparison
LEE vs PLX Comparison
Compare LEE & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEE | PLX |
|---|---|---|
| Founded | 1890 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.8M | 182.9M |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LEE | PLX |
|---|---|---|
| Price | $8.27 | $2.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 42.5K | ★ 715.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $543,955,000.00 | $52,744,000.00 |
| Revenue This Year | $5.48 | $36.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $1.52 |
| 52 Week High | $11.88 | $3.19 |
Technical Indicators
Market Signals| Indicator | LEE | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 50.75 |
| Support Level | $7.14 | $2.18 |
| Resistance Level | $9.27 | $2.43 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 18.64 | 37.38 |
Price Performance
Historical ComparisonAbout LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.